Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Neuromuscular Disorders : NMD
|
June 29, 2010
Calpainopathy presenting as foot drop in a 41 year old
G Burke, C Hillier, J Cole, et al.
Clinical Genetics
|
July 14, 2016
Muscle hypertrophy as the presenting sign in a patient with a complete FHL1 deletion
T A Willis, C L Wood, J Hudson, et al.
The Journal of Clinical Investigation
|
August 1, 1995
Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine
P Bernasconi, E Torchiana, P Confalonieri, et al.
Muscle & Nerve
|
October 1, 1994
Fetus-like dystrophin expression and other cytoskeletal protein abnormalities in centronuclear myopathies
M Mora, L Morandi, L Merlini, et al.
Journal of the Neurological Sciences
|
October 1, 1995
Dystrophin characterization in BMD patients: correlation of abnormal protein with clinical phenotype
L Morandi, M Mora, V Confalonieri, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 18, 2009
Inclusion body myopathy with Paget disease and frontotemporal dementia (IBMPFD): clinical features including sphincter disturbance in a large pedigree
T D Miller, A P Jackson, R Barresi, et al.
Journal of Medical Genetics
|
February 9, 2000
Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations
R Barresi, C Di Blasi, T Negri, et al.
Transfusion Science
|
June 1, 2000
PCR testing for HCV in anti-HCV negative blood donors involved in the so called HCV +ve post-transfusion hepatitis
M R Ruzzenenti, M C De Luigi, R Bruni, et al.
Neurology
|
April 2, 2008
A refined diagnostic algorithm for Bethlem myopathy
D Hicks, A K Lampe, R Barresi, et al.
Neuromuscular Disorders : NMD
|
April 9, 2008
Late onset in dysferlinopathy widens the clinical spectrum
L Klinge, A F Dean, W Kress, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Neuromuscular Disorders : NMD
|
June 29, 2010
Calpainopathy presenting as foot drop in a 41 year old
G Burke, C Hillier, J Cole, et al.
Clinical Genetics
|
July 14, 2016
Muscle hypertrophy as the presenting sign in a patient with a complete FHL1 deletion
T A Willis, C L Wood, J Hudson, et al.
The Journal of Clinical Investigation
|
August 1, 1995
Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine
P Bernasconi, E Torchiana, P Confalonieri, et al.
Muscle & Nerve
|
October 1, 1994
Fetus-like dystrophin expression and other cytoskeletal protein abnormalities in centronuclear myopathies
M Mora, L Morandi, L Merlini, et al.
Journal of the Neurological Sciences
|
October 1, 1995
Dystrophin characterization in BMD patients: correlation of abnormal protein with clinical phenotype
L Morandi, M Mora, V Confalonieri, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 18, 2009
Inclusion body myopathy with Paget disease and frontotemporal dementia (IBMPFD): clinical features including sphincter disturbance in a large pedigree
T D Miller, A P Jackson, R Barresi, et al.
Journal of Medical Genetics
|
February 9, 2000
Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations
R Barresi, C Di Blasi, T Negri, et al.
Transfusion Science
|
June 1, 2000
PCR testing for HCV in anti-HCV negative blood donors involved in the so called HCV +ve post-transfusion hepatitis
M R Ruzzenenti, M C De Luigi, R Bruni, et al.
Neurology
|
April 2, 2008
A refined diagnostic algorithm for Bethlem myopathy
D Hicks, A K Lampe, R Barresi, et al.
Neuromuscular Disorders : NMD
|
April 9, 2008
Late onset in dysferlinopathy widens the clinical spectrum
L Klinge, A F Dean, W Kress, et al.
Page
of 4